Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received February 7, 2016
- Revision received April 2, 2016
- Accepted April 7, 2016
- Published online April 28, 2016.
Copyright & Usage
Copyright© 2016 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved
Author Information
- 1Laboratory for Process Engineering, Environment, Biotechnology and Energy (LEPABE), Chemical Engineering Department, Engineering Faculty, University of Porto, Porto, Portugal
- 2Molecular Oncology Group, IPO-Porto Research Centre (CI-IPOP) and Virology Laboratory, Portuguese Oncology Institute, Porto, Portugal
- 3Abel Salazar Institute for Biomedical Sciences, University of Porto, Porto, Portugal
- 4Biomedicine Research Centre, Health Sciences Faculty, Fernando Pessoa University, Porto, Portugal
- 5Research Department, Portuguese League against Cancer, Porto, Portugal
- 6Biological and Agroenvironmental Technology Research Centre (CITAB), University of Trás-os-Montes and Alto Douro, Vila Real, Portugal
- Correspondence to: Professor Paula A. Oliveira, Departamento de Ciências Veterinárias, Universidade de Trás-os-Montes e Alto Douro (UTAD), Quinta de Prados, 5000-801, Vila Real, Portugal. Tel: +351 259350000, Fax: +351 259350480, e-mail: pamo{at}utad.pt
In this issue
Jump to section
Related Articles
Cited By...
- Standardized Uptake Value for 18F-Fluorodeoxyglucose Is a Marker of Inflammatory State and Immune Infiltrate in Cervical Cancer
- Penicillium purpurogenum exerts antitumor effects and ameliorates inflammations in Erlich mice model
- Human Papillomavirus 16 E5 Inhibits Interferon Signaling and Supports Episomal Viral Maintenance
- HPV18 Persistence Impairs Basal and DNA Ligand-Mediated IFN-{beta} and IFN-{lambda}1 Production through Transcriptional Repression of Multiple Downstream Effectors of Pattern Recognition Receptor Signaling
- Curcumin and Rutin Down-regulate Cyclooxygenase-2 and Reduce Tumor-associated Inflammation in HPV16-Transgenic Mice
- Regulation of miRNA-146a and miRNA-150 Levels by Celecoxib in Premalignant Lesions of K14-HPV16 Mice